|

Use of Export in Primary Percutaneous Coronary Intervention

RECRUITINGN/ASponsored by National Institute of Cardiovascular Diseases, Pakistan
Actively Recruiting
PhaseN/A
SponsorNational Institute of Cardiovascular Diseases, Pakistan
Started2024-01-15
Est. completion2025-05-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05510661

Summary

Aim of this single center randomized open label trial with blinded in-hospital outcomes assessment is designed with aim to compare manual thrombus aspiration followed by percutaneous coronary intervention (PCI) strategy with PCI alone.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients presenting with:-Symptoms of myocardial ischemia lasting for ≥30 minutes
* Definite ECG changes indicating STEMI: ST elevation of greater than 0.1 mV in two contiguous limb leads or 0.2 mV in two contiguous precordial leads
* Chest pain \< 12 hours duration
* Total occlusion (TIMI 0 flow)
* Patients undergoing primary PCI
* Informed consent

Exclusion Criteria:

* Patients with prior history of cardiac related surgery or intervention
* Performance of a rescue PCI after thrombolysis
* Known existence of a disease resulting in a life expectancy of less than 6 months
* Killip class III, IV

Conditions4

Heart DiseasePrimary Percutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)Total Occlusion of Coronary Artery

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.